Apex Biotechnology Corp (1733) — Capital Reinvestment Ratio
Apex Biotechnology Corp (1733) has a Capital Reinvestment Ratio of 0.57x as of September 2025, meaning it reinvests 1% of its operating cash flow (NT$5.19 Million) in capital expenditures (NT$2.97 Million). See Apex Biotechnology Corp (1733) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Apex Biotechnology Corp Capital Reinvestment Ratio (2002–2024)
This chart tracks Apex Biotechnology Corp's Capital Reinvestment Ratio across 23 annual periods. Check Apex Biotechnology Corp (1733) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Apex Biotechnology Corp (2002–2024)
Year-by-year Capital Reinvestment Ratio for Apex Biotechnology Corp from 2002 to 2024. For live market cap and broader valuation context, see Apex Biotechnology Corp stock valuation.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.09x | NT$328.67 Million | NT$29.63 Million | ▼ -16.8% |
| 2023 | 0.11x | NT$230.39 Million | NT$24.98 Million | ▼ -92.8% |
| 2022 | 1.51x | NT$26.62 Million | NT$40.20 Million | ▲ +936.9% |
| 2021 | 0.15x | NT$179.87 Million | NT$26.20 Million | ▼ -15.4% |
| 2020 | 0.17x | NT$280.60 Million | NT$48.32 Million | ▲ +40.8% |
| 2019 | 0.12x | NT$462.52 Million | NT$56.58 Million | ▼ -89.0% |
| 2018 | 1.11x | NT$67.57 Million | NT$75.29 Million | ▲ +194.9% |
| 2017 | 0.38x | NT$70.83 Million | NT$26.76 Million | ▲ +192.8% |
| 2016 | 0.13x | NT$298.06 Million | NT$38.45 Million | ▲ +128.5% |
| 2015 | 0.06x | NT$472.15 Million | NT$26.66 Million | ▼ -76.9% |
| 2014 | 0.24x | NT$267.60 Million | NT$65.41 Million | ▼ -52.2% |
| 2013 | 0.51x | NT$484.77 Million | NT$247.69 Million | ▼ -37.2% |
| 2012 | 0.81x | NT$509.67 Million | NT$414.70 Million | ▲ +198.1% |
| 2011 | 0.27x | NT$273.45 Million | NT$74.63 Million | ▼ -21.1% |
| 2010 | 0.35x | NT$465.59 Million | NT$161.05 Million | ▲ +84.6% |
| 2009 | 0.19x | NT$391.29 Million | NT$73.34 Million | ▼ -56.7% |
| 2008 | 0.43x | NT$299.96 Million | NT$129.74 Million | ▲ +188.3% |
| 2007 | 0.15x | NT$364.62 Million | NT$54.71 Million | ▲ +30.0% |
| 2006 | 0.12x | NT$363.71 Million | NT$41.99 Million | ▼ -69.9% |
| 2005 | 0.38x | NT$212.14 Million | NT$81.30 Million | ▼ -66.7% |
| 2004 | 1.15x | NT$218.54 Million | NT$251.16 Million | ▲ +518.0% |
| 2003 | 0.19x | NT$302.25 Million | NT$56.21 Million | ▼ -75.8% |
| 2002 | 0.77x | NT$79.49 Million | NT$61.13 Million | — |